Latest News

New Technology Will Improve Diagnostics Helping Solve Equine Health Mysteries


Newark, Calif. – June 29, 2022 ( Newswire) Prisma Imaging is a biotech company, founded by Michael Silver, that has developed the next generation of equine diagnostic imaging. This technology allows veterinarians access to high-quality images of the entire horse – even the axial skeleton and high-mass areas not accessible by other systems – while the horse remains standing and conscious. This is a game-changer providing a new level of diagnosis, treatment and better overall equine health care.

Be Part Of The Next Generation Of Equine Imaging

Prisma is raising capital via an equity crowdfunding campaign on StartEngine providing an opportunity for the public to join the mission to revolutionize the equine diagnostic imaging industry. Prisma is offering incentives such as 10% bonus shares and extra rewards based on the investment amount.

Crowdfunding investments will help accelerate the availability of Prisma’s technology and significantly benefit the performance, safety, care and quality of life for horses.

Learn More

Three Major Innovations

The Prisma Difference

The Use of Robotics Gives Prisma’s System Unmatched Capabilities

Unlike current imaging systems, which have numerous limitations and cannot gain access to many parts of the equine anatomy, Prisma’s use of robotics provides the ability to image virtually every anatomical region of a standing, conscious horse.

Prisma’s System Integrates Two Types of Radiographic Imaging Technology

The application of these dual techniques enables imaging of the high-mass areas of the equine anatomy including the axial skeleton, hips, pelvis, and abdomen, which are not accessible with current imaging technology, and generates maximum data capture for high-resolution CT images.

Motion Correction – A Key, Novel Feature of Prisma’s Imaging System

Our motion correction system compensates for movement while scanning a conscious, standing horse and integrates the data into the system. Closely monitoring the patient’s precise location while being scanned makes it possible to obtain high-quality results despite the movement of the conscious subject which may occur during imaging, and avoids the need to use anesthesia.

To See How The Technology Works, Please Watch The Brief Video.

More Info:

This news is published on the Newswire – a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy: – investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Buy a biotech guest post on

Rebounding Crude Oil Gets Far Away from the Bearish Side

Previous article

1 “Digital Twin” Stock Price Target: $298!

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News